[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eyepoint Inc (EYPT)

Eyepoint Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 431,491
  • Shares Outstanding, K 86,212
  • Annual Sales, $ 31,370 K
  • Annual Income, $ -231,960 K
  • EBIT $ -317 M
  • EBITDA $ -320 M
  • 60-Month Beta 1.76
  • Price/Sales 13.38
  • Price/Cash Flow N/A
  • Price/Book 2.45

Options Overview Details

View History
  • Implied Volatility 114.84% (+1.31%)
  • Historical Volatility 330.92%
  • IV Percentile 69%
  • IV Rank 16.90%
  • IV High 375.77% on 08/14/26
  • IV Low 61.78% on 05/21/26
  • Expected Move (DTE 22) 0.81 (16.18%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 994
  • Volume Avg (30-Day) 11,014
  • Put/Call OI Ratio 0.63
  • Today's Open Interest 138,151
  • Open Int (30-Day) 90,380
  • Expected Range 4.18 to 5.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.81
  • Number of Estimates 4
  • High Estimate $-0.60
  • Low Estimate $-0.95
  • Prior Year $-0.85
  • Growth Rate Est. (year over year) +4.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.95 +26.33%
on 08/17/26
14.76 -66.19%
on 08/14/26
-7.20 (-59.06%)
since 07/24/26
3-Month
3.95 +26.33%
on 08/17/26
15.92 -68.66%
on 07/01/26
-8.36 (-62.62%)
since 05/26/26
52-Week
3.95 +26.33%
on 08/17/26
19.11 -73.89%
on 12/08/25
-7.05 (-58.55%)
since 08/26/25

Most Recent Stories

More News
NASDAQ: EYPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the Firm

Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by EyePoint,...

EYPT : 4.99 (-0.30%)
EyePoint Pharmaceuticals (EYPT) Securities Investigation Notice - Levi & Korsinsky

EyePoint Pharmaceuticals shares opened down approximately 70% after the Company disclosed that DURAVYU missed the prespecified primary endpoint in the Phase 3 LUGANO trial. Levi & Korsinsky is investigating...

EYPT : 4.99 (-0.30%)
EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into EyePoint Pharmaceuticals (EYPT)

EyePoint Pharmaceuticals shareholders lost nearly 67% of their share value in a single session after the Phase 3 LUGANO topline readout. Levi & Korsinsky is investigating the losses on behalf of EYPT investors....

EYPT : 4.99 (-0.30%)
EYPT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving EyePoint Pharmaceuticals

EyePoint Pharmaceuticals told investors its Phase 3 wet AMD program was "on track" days before disclosing that DURAVYU missed the prespecified primary endpoint. SueWallSt notifies investors of a pending...

EYPT : 4.99 (-0.30%)
These 2 Stocks Are Setting Off Technical Alarm Bells with $1,000+ Price Tags. Here’s the Company I’d Bet on for the Long Term.

Graham Holdings (GHC) was a bearish price surprise on Monday, down 2.2%. At the same time, Biglari Holdings (BH.A) was a bullish price surprise, up 3.56%. Both holding companies have diversified businesses....

GHC : 1,163.24 (-1.30%)
BH.A : 1,954.61 (+0.38%)
CBRL : 58.56 (+0.49%)
EYPT : 4.99 (-0.30%)
IPST : 5.99 (-23.01%)
Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff

September Nasdaq 100 E-Mini futures (NQU26) are down -1.21% this morning as a global bond rout sapped investors’ appetite for risk, triggering a selloff in chip and other AI-related stocks.

META : 576.14 (+1.07%)
NVDA : 209.66 (-1.59%)
SNDK : 1,499.37 (+1.26%)
NQU26 : 29,653.00 (+1.24%)
MU : 938.40 (+0.58%)
FN : 437.80 (+1.45%)
TRI : 102.45 (-1.85%)
HUBN.Z.EB : 171.600 (+3.00%)
MSFT : 496.37 (+0.95%)
TOL : 148.18 (-1.76%)
TSLA : 345.82 (-1.26%)
INTC : 88.24 (+0.87%)
Stocks Settle Lower on Rising Crude Prices and Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) closed down by -0.52% on Monday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down by -0.17%....

ALK : 43.00 (-0.76%)
SNDK : 1,499.37 (+1.26%)
TRI : 102.45 (-1.85%)
OXY : 58.62 (+0.36%)
FANG : 199.84 (-0.03%)
STX : 846.37 (+3.01%)
WDC : 468.88 (+4.02%)
EYPT : 4.99 (-0.30%)
STZ : 134.45 (-0.41%)
SPY : 766.08 (+0.02%)
ADSK : 254.77 (+1.42%)
MU : 938.40 (+0.58%)
Stock Indices Waver on Strength in Chipmakers vs Weakness in Software Companies

The S&P 500 Index ($SPX ) (SPY ) is down by -0.15% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.44%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.28%. E-mini S&P futures...

AMAT : 479.76 (-0.06%)
AVGO : 355.59 (-0.32%)
SNDK : 1,499.37 (+1.26%)
INTU : 345.88 (-3.24%)
ADI : 371.80 (-0.50%)
DDOG : 227.67 (+2.10%)
TXN : 261.77 (+0.66%)
$IUXX : 29,224.52 (+0.05%)
ASML : 1,745.64 (+0.08%)
ZNU26 : 108-225 (+0.04%)
MSFT : 496.37 (+0.95%)
ALAB : 290.30 (+2.71%)
Stocks Mixed on Strength in Chipmakers vs Weakness in Software Companies

The S&P 500 Index ($SPX ) (SPY ) is up by +0.17% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.13%. E-mini S&P futures (ESU26...

AMAT : 479.76 (-0.06%)
SNDK : 1,499.37 (+1.26%)
INTU : 345.88 (-3.24%)
DDOG : 227.67 (+2.10%)
TXN : 261.77 (+0.66%)
$IUXX : 29,224.52 (+0.05%)
ASML : 1,745.64 (+0.08%)
ZNU26 : 108-225 (+0.04%)
MSFT : 496.37 (+0.95%)
ALAB : 290.30 (+2.71%)
S : 20.51 (+0.98%)
ESU26 : 7,732.25 (+0.55%)
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD

– DURAVYU was non-inferior to on-label aflibercept control (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (≥ 15 letters)...

EYPT : 4.99 (-0.30%)

Business Summary

EYEPOINT INC is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. EYEPOINT INC, formerly known as EyePoint Pharmaceuticals Inc., is based in WATERTOWN, Mass.

See More

Key Turning Points

3rd Resistance Point 5.20
2nd Resistance Point 5.14
1st Resistance Point 5.06
Last Price 4.99
1st Support Level 4.92
2nd Support Level 4.86
3rd Support Level 4.78

See More

52-Week High 19.11
Fibonacci 61.8% 13.32
Fibonacci 50% 11.53
Fibonacci 38.2% 9.74
Last Price 4.99
52-Week Low 3.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.